Phase 3 Perioperative Nivolumab in M0 RCC (PROSPER RCC, ECOG ACRIN 8143) A UROLOGISTS PERSPECTIVE

Mohamad E. Allaf, MD, Associate Professor of Urology, Oncology, & BME MEA Endowed Director, Minimally Invasive Surgery<br />Johns Hopkins Medicine presents Phase 3 Perioperative Nivolumab in M0 RCC (PROS... Author: kidneycancer Added: 11/05/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts